Neurotransmitter homeostasis is important for proper synaptic signal transmission. Synaptically released neurotransmitters are recycled by direct reuptake into the presynaptic terminal and/or uptake into perisynaptic astrocyte processes. In the latter case, most neurotransmitters are metabolized and shuttled back to the presynaptic terminal to restore the neurotransmitter content in that compartment. In various regions of the central nervous system (CNS), the neurotransmitters glycine and GABA are heterogeneously utilized for inhibition of neuronal activity -glycine predominantly in caudal regions, GABA predominantly in rostral ones. Accordingly, respective transporters are used in neurons and astrocytes. Both cell types utilize different members of the neurotransmitter transporter family in a region-dependent manner. While glycine transporter (GlyT) 1 is predominantly utilized in astrocytes, GlyT2 is prevailing in neurons. The GABA transporters (GAT)-1 and -3 are not distinctly attributed to neurons or astrocytes, and transporter localization depends on the CNS region. Additionally, there is a complex interplay of different neurotransmitters and respective transporters as the uptake of one neurotransmitter into neurons as well as astrocytes can trigger the release of other transmitters from both cell types. This review summarizes the heterogeneous distribution and utilization of the four inhibitory neurotransmitter transporters GlyT1, GlyT2, GAT-1, and GAT-3 in olfactory bulb, retina, cortex, hippocampus, cerebellum, brainstem, thalamus, and spinal cord. Furthermore, it elaborates possible functional consequences of the transporter interplay for neurotransmitter homeostasis.
Introduction
The inhibitory neurotransmitter transporters GlyT1, GlyT2, GAT-1, and GAT-3 belong to the solute carrier family 6 (Slc6). They are composed of 12 transmembrane segments and transporter-specific N-and C-terminal domains ( Figure 1A ). Each transporter is electrogenic and three of them share the same stoichiometry (Na + : Cl -: Glycine/GABA): GlyT1 (Slc1A9; 2 : 1 : 1), GlyT2 (Slc1A5; 3 : 1 : 1), GAT-1 (Slc1A1; 2 : 1 : 1), and GAT-3 (Slc1A11; 2 : 1 : 1; Figure 1B ) [1] [2] [3] [4] . Thus, the uptake of glycine or GABA via inhibitory neurotransmitter transporters causes an inward current [3, [5] [6] [7] [8] [9] and concomitant depolarization [7] .
Glycine-mediated inhibition is predominant in brainstem and spinal cord, whereas GABA-mediated inhibition takes is prevalent in rostral brain regions. Nevertheless, the composition of inhibitory neurotransmitter transporters and their specificity for distinct cell types depends on the brain region [10] [11] [12] . GlyT1 and GAT-3 have long been considered to be located in astrocytes, whereas GlyT2 and GAT-3 were postulated to be utilized in neurons. However, results from in REVIEW situ hybridization and immunohistochemistry levels did not reveal conclusive evidence for cell type specificity. Meanwhile, the initially proposed distribution of inhibitory neurotransmitter transporters has been challenged, and a high heterogeneity regarding cell type specificity of GlyTs and GATs was frequently shown (Table 1) . For a detailed analysis of cell type-specific utilization of respective transporters, different techniques are used: Whole-cell patch-clamp, immunohistochemistry, electron microscopy, or uptake/release assays using [ 3 H]-labeled glycine or GABA. Functional analysis is done in acute tissue slices, freshly isolated cells, primary neuronal and astrocytic cultures, synaptosomes, gliosomes, and heterologous expression systems ( Table 1) .
Properties of inhibitory neurotransmitter transporters
The transport activity of the four secondary active inhibitory neurotransmitter transporters mainly depends on the Na + gradient across the membrane (Figure 1 ). Taking the different stoichiometry of the transporters into account, only GlyT1, GAT-1, and GAT-3 are able to work bidirectionally under physiological conditions, whereas GlyT2 exclusively mediates glycine uptake [13, 14] . In addition to Na + , the transport requires all co-substrates. Consequently, GlyT1 activity depends on [ [20] . Together with [Gly] i and [GABA] i of about 2mM, respectively, astrocytes promote GlyT1 and GAT reversal under physiological conditions [14, 20, 21] .
Interference of neurotransmitter transporters
The regulation of neurotransmitter uptake modulates inhibitory synaptic transmission and postsynaptic signal integration [22] . Transporter regulation not only depends on ion and neurotransmitter gradients [18] , but can also be achieved via intracellular signaling [23, 24] through interaction with N-and C-termini of the transporters [25, 26] . Furthermore, as the reversal potential of GlyT1 and GATs is close to the resting E M of astrocytes under physiological conditions those transporters can be easily forced into reverse mode by Figure 2 ) [17, 20] . Thus, astrocytes can directly serve tonic inhibition of neuronal network activity [27, 28] .For reviews on tonic and phasic inhibition, see [29, 30] . Furthermore, as glycine is a co-agonist of NMDA receptors, it can directly modulate glutamatergic synaptic transmission. GlyT1-mediated release of glycine has been shown to alter NMDA receptor-mediated signaling [13, 31] . Inhibition of GlyT1-mediated glycine uptake was shown to facilitate NMDA receptor-mediated currents and long-term potentiation as well as axonal sprouting [32, 33] . Regarding GABA release, not only activation of ionotropic GABA A receptors is of interest, but also activation of the high-affinity metabotropic GABA B receptors. Indeed, regulation of GAT activity modulates GABA B receptor function [34] .
Besides regulated neurotransmitter transporter-mediated uptake and release, the interplay of different neurotransmitters can have manifold effects. The most obvious interplay of two neurotransmitters takes place at mixed inhibitory synapses, which co-release glycine and GABA. Such synapses are present in various CNS regions, e.g. cerebellum, brainstem, and spinal cord [35] [36] [37] [38] [39] [40] [41] [42] . Here, two mechanisms can lead to neurotransmitter release: 1) vesicle fusion and 2) transporter reversal. In presynaptic terminals, glycine and GABA concur on the binding site of the vesicular inhibitory amino acid transporter (VIAAT), which mediates the filling of vesicles with both neurotransmitters, depending on the ratio of available neurotransmitters [42] . Glutamate uptake into these mixed inhibitory presynaptic terminals via neuron-specific glutamate transporters leads to production of GABA by degradation of glutamate via the glutamic acid decarboxylase (GAD) [37, 42, 43] . Consecutively, GABA can replace glycine at VIAAT, thus giving the synapse a more GABAergic phenotype, which alters the kinetics of inhibitory postsynaptic currents [37] . Besides altering the vesicular content, electrogenic glutamate uptake (stoichiometry: 3Na + : 1 glutamate : 1H + against 1K + ) [44] causing reduction of the electrical and Na + gradient and synthesis of GABA -induces GAT reversal and consecutive GABA release [37, 43] . Additionally, GlyT2 activity in neurons can trigger GABA release via GAT reversal [45] . Thus, release of glycine and/or GABA depends on the distribution and amount of both neurotransmitters as well as the interplay of different transporters.
Astrocytes in many brain regions simultaneously utilize GlyTs and GATs (cf. Table 1 ). As both neurotransmitter transporters are linked to the chemical gradient of Na + and Cl -as well as astrocytic E M they can reciprocally reduce their activity [7] . Furthermore, uptake of glutamate into astrocytes after excitatory synaptic transmission can lead to production and release of GABA via GAT reversal (Figure 2 ) [43, 46] . Additionally, glycinergic synaptic transmission may trigger GABA release via GAT reversal as well (Figure 2) .
Independent from the possible effect of GAT activity on neuronal signaling, inhibitory glycinergic transmission will cause an increase of [Na + ] i and [Cl -] i and depolarization of astrocytes, which subsequently enables glycine release via transporter reversal (Figure 2) . If the release site is located near excitatory glutamatergic terminals, released glycine can act as a co-agonist on postsynaptic NMDA receptors and modulate synaptic transmission [13] .
Conclusion
Both, the transport activity and the direction of neurotransmitter transport depend on the chemical (Na [20] , neurotransmitter transporters can reverse under physiological conditions and mediate transmitter release [14, 20] . The transporters are heterogeneously distributed within the CNS and utilized by both neurons and astrocytes (cf. Table 1) causing a brain region-dependent interplay.
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